Nerve Pain Articles & Analysis
21 news found
At best, most of us tolerate needles. Whether a vaccine, an IV drip, or a blood draw, we can talk ourselves through it with the knowledge that it is for the greater good and will only cause temporary discomfort. On the other side of the spectrum, there are people with such an intense fear of needles that they are considered to have a phobia, trypanophobia to be precise. Many articles have been ...
(Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that gammaCore Sapphire™, the first and only FDA-cleared, non-invasive device to treat and prevent multiple types of headache pain via the vagus nerve, will be distributed and billed exclusively by Joerns Healthcare, LLC (Joerns) within selected managed care health systems. ...
In some situations the doctor may require additional testing, bone scans, or nerve studies. Patients may need follow-up injections over a six-month period to ensure consistent pain relief. ...
The spinal cord, nerve root, lumbosacral nerve root, brachial plexus and ulnar nerve are common sites of injury. Regional anesthetics are more likely to cause issues with the spine and lumbosacral nerve root. Nerve root injury usually causes a lot of pain, most often resulting from subtly ...
Results from the acute treatment of migraine with external trigeminal nerve stimulation double-blind randomized placebo control trial were presented at a recent meeting of the International Headache Society. The findings showed that on average, the Cefaly® treatment reduced migraine pain by 65%. In addition, 32% of patients were pain free ...
ByCEFALY
” The minimally invasive Intracept Procedure is the only FDA cleared treatment for chronic vertebrogenic low back pain. It uses targeted radiofrequency energy to stop the basivertebral nerve from carrying pain signals to the brain. ...
The study is the first to prove that external concurrent stimulation of both the occipital and trigeminal nerves can effectively treat migraine pain, with 76% of patients achieving headache relief within 2 hours compared to 31.6% of patients in the sham group. ...
” BioWave is a patented smarter pain blocking technology that provides immediate, deep, long lasting relief of severe pain. BioWave devices deliver therapeutic electrical signals through skin directly to pain nerves in deep tissue to prevent pain signals from reaching the brain relieving chronic, acute or ...
Prior to enrollment, each participating subject was screened and verified to have met all eligibility criteria, including: having early to moderate symptomatic, single-level DDD from L3-S1, no previous lumbar spine surgery, no radiculopathy (pinched nerve) or leg pain, and no comorbidities, such as tumors, fibromyalgia, systemic disease, osteoarthritis or chronic ...
He was unable to work, sleep, or function in daily life. Pain medication provided little relief. Thankfully, Chris was referred to a surgeon who specializes in nerve repair. The surgeon explained that nerves injured during the amputation were the cause of the pain and recommended surgical nerve repair. During the ...
The resulting inflammatory cascade can be observed on standard magnetic resonance imaging (MRI) as Modic changes – enabling patients with vertebrogenic pain to be diagnosed via an objective biomarker. The inflammatory environment irritates the basivertebral nerve (located within the vertebral body), which transmits pain signals to the ...
Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced today the completion of enrollment in its pivotal QUEST (High-FreQUEncy Nerve Block for PoST-Amputation Pain) study. ...
Food and Drug Administration (FDA) for the use of its novel High-Frequency Nerve Block system as an aid in the management of chronic intractable pain of the lower limb of adult amputees. ...
Baron’s research focuses on exploring the mechanisms behind the formation of nerve pain, as well as the treatment of neuropathic pain syndromes. He was involved in developing a mechanism-related phenotyping strategy for neuropathic pain patients. ...
Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced today the close of a Series BB financing totaling $38.5 million. ...
Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced today the achievement of two milestones in its pivotal QUEST (High-FreQUEncy Nerve Block for PoST-Amputation Pain) study. ...
His research interests are in neural engineering and neuromodulation and include model-based design and analysis and quantitative physiology with applications to restoration of bladder function, treatment of movement disorders with deep brain stimulation, electrical stimulation for treatment of pain, and vagus nerve stimulation for regulation of organ function. ...
If these findings can be replicated in humans, it could result in reduced pain and disability, making IDCT an extremely attractive therapeutic candidate for the unmet medical need of one of the most common causes of chronic low back ...
Supportive care – Specialized medical care that focuses on providing relief from pain and other symptoms of a serious illness. New Hope for Glioblastoma Patients Clinical trials are used to determine if a new treatment or device offers any benefit or advantage over what is currently available. ...
“We will utilize these funds to complete our initial pivotal IDE clinical study, which is evaluating the use of our patented Altius® System High Frequency Nerve Block technology for the man agement of post-amputation pain, and, ultimately, to secure Pre-Market Approval (PMA) from the Food & Drug Administration (FDA) . ...